Biogenic Silver Nanoparticles for Targeted Cancer Therapy and Enhancing Photodynamic Therapy

Author:

Kah Glory1ORCID,Chandran Rahul1ORCID,Abrahamse Heidi1ORCID

Affiliation:

1. Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Johannesburg 2028, South Africa

Abstract

Different conventional therapeutic procedures are utilized globally to manage cancer cases, yet the mortality rate in patients with cancer remains considerably high. Developments in the field of nanotechnology have included novel therapeutic strategies to deal with cancer. Biogenic (green) metallic silver nanoparticles (AgNPs) obtained using plant-mediated protocols are attractive to researchers exploring cancer treatment. Biogenic AgNPs present advantages, since they are cost-effective, easy to obtain, energy efficient, and less toxic compared to chemically and physically obtained AgNPs. Also, they present excellent anticancer abilities thanks to their unique sizes, shapes, and optical properties. This review provides recent advancements in exploring biogenic AgNPs as a drug or agent for cancer treatment. Thus, great attention was paid to the anticancer efficacy of biogenic AgNPs, their anticancer mechanisms, their efficacy in cancer photodynamic therapy (PDT), their efficacy in targeted cancer therapy, and their toxicity.

Funder

South African Research Chairs Initiative

National Research Foundation of South Africa

University of Johannesburg

Publisher

MDPI AG

Subject

General Medicine

Reference177 articles.

1. Photodynamic Ability of Silver Nanoparticles in Inducing Cytotoxic Effects in Breast and Lung Cancer Cell Lines;Hussein;Int. J. Nanomed.,2014

2. Optimization, Characterization and Antimicrobial Activity of Silver Nanoparticles against Plant Bacterial Pathogens Phyto-Synthesized by Mentha Longifolia;Javed;Mater. Res. Express,2020

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

4. Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview;Abbasi;Nanotheranostics,2022

5. The Different Mechanisms of Cancer Drug Resistance: A Brief Review;Mansoori;Adv. Pharm. Bull.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3